Skip to main content Skip to section navigation Skip to footer
Aethlon Medical, Inc. Corporate Home
  • The Hemopurifier®
    • Overview
    • The Hemopurifier® in Cancer
    • The Hemopurifier® in Infectious Disease
  • About
    • Overview
    • Leadership
    • Board of Directors
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Publications
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Analyst Coverage
  • Contact Us
Site Announcement

Aethlon Medical is closely monitoring the Bird Flu situation and stands ready to work alongside hospitals, health agencies and the FDA if existing therapies prove inadequate.

Investors
  • Overview
  • Corporate News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Leadership
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • IRS Form 8937 for 2019 Reverse Stock Split
    • IRS Form 8937 for 2023 Reverse Stock Split
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Governance Documents
  • Analyst Coverage

Press Releases

  • Corporate News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 12, 2015

Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study

May 4, 2015

Aethlon Medical Announces Withdrawal of S-1 Registration Statement

Apr 16, 2015

Aethlon Medical Discloses Presentation of Preliminary CTE Related Study Results

Apr 15, 2015

Aethlon Medical Announces Cancer Clinical Trial Agreement

Apr 14, 2015

Aethlon Medical Announces Effectiveness of Reverse Stock Split

Apr 9, 2015

Aethlon Medical Announces Ebola Humanitarian Use Device Submission to the FDA

Apr 8, 2015

Aethlon Medical Announces Reverse Stock Split and Nasdaq Listing Submission

Apr 2, 2015

Aethlon Medical Discloses Head and Neck Cancer Collaboration

Mar 6, 2015

Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference

Mar 4, 2015

Aethlon Medical to Present at the 27th Annual ROTH Conference

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Linkedin
Privacy Policy Disclaimer Sitemap Accessibility Statement
©2025 Aethlon Medical, Inc. All Rights Reserved.